{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:07:00Z","timestamp":1766621220546,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The 2019 American Thoracic Society and Infectious Diseases Society of America community acquired pneumonia guidelines recommend empiric coverage of methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      based on previous respiratory isolation, recent IV antibiotic use, and locally validated risk factors. This study aims to describe how local risk factors may be determined efficiently using data retrieved electronically.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study focused on the time period May 13, 2020, through June 30, 2024. Consecutive adults admitted to one of five acute care facilities with confirmed community-acquired pneumonia were included. Community-acquired pneumonia was defined as the presence of one or more pneumonia diagnosis codes and an order for a respiratory culture or an antimicrobial with the indication of pneumonia or sepsis, 24\u00a0h before or within 48\u00a0h after the date and time of admission. Patients were excluded if they had a diagnosis code for hospital-acquired or ventilator-associated pneumonia, any subsequent admission in the study period, or if they had a previous respiratory culture positive for methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      or\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      within a year of admission. The causative pathogen and the presence or absence of evaluated risk factors were electronically abstracted from billing data and health records. Serial quality assessments of electronic data were performed to improve accuracy until a well validated population was determined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 4,558 unique patients included. Methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      rates were 0.6% and 0.7%, respectively. Only age was inversely associated with risk of methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (OR\u2009=\u20090.86, 95% CI: 0.76\u20130.98). No significant risk factors for\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      were found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In rural or otherwise resource limited healthcare settings, risk factors for methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      community-acquired pneumonia may be determined using only electronic data capture and the methodology described in this article.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41479-025-00188-6","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:02:50Z","timestamp":1766620970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating risk factors for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in community acquired pneumonia: a model for using only electronic data capture"],"prefix":"10.1186","volume":"17","author":[{"given":"Philip Logan","family":"Whitfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Wendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Gabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Ridder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"188_CR1","unstructured":"National Center for Health Statistics-Leading Causes of Death. Centers for Disease Control and Prevention. 2022. https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm. Accessed November 11, 2024."},{"issue":"7","key":"188_CR2","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u2013367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"188_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","unstructured":"American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"188_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1060028020935106","volume":"55","author":"PO Lewis","year":"2021","unstructured":"Lewis PO. Risk factor evaluation for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in community-acquired pneumonia. Ann Pharmacother. 2021;55(1):36\u201343.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"188_CR5","first-page":"169","volume":"53","author":"S Soedarsono","year":"2021","unstructured":"Soedarsono S, Widayaningsih PD, Mertaniasih NM. The risk factors of multidrug-resistant organisms in hospitalized patients with community-acquired pneumonia in Dr. Soetomo hospital Surabaya, Indonesia. Acta Med Indones. 2021;53(2):169\u201376.","journal-title":"Acta Med Indones"},{"issue":"2","key":"188_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/08971900211039700","volume":"36","author":"EW Covington","year":"2023","unstructured":"Covington EW, Rufe A. Identification of risk factors for Multidrug-Resistant organisms in community-Acquired bacterial pneumonia at a community hospital. J Pharm Pract. 2023;36(2):303\u20138.","journal-title":"J Pharm Pract"},{"issue":"6","key":"188_CR7","doi-asserted-by":"publisher","first-page":"e13061","DOI":"10.1002\/emp2.13061","volume":"4","author":"BW Frazee","year":"2023","unstructured":"Frazee BW, Singh A, Labreche M, et al. Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa community acquired pneumonia: prevalence and locally derived risk factors in a single hospital system. J Am Coll Emerg Physicians Open. 2023;4(6):e13061.","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"2","key":"188_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","volume":"12","author":"E Prina","year":"2015","unstructured":"Prina E, Ranzani OT, Polverino E, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thorac Soc. 2015;12(2):153\u201360.","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"188_CR9","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/jac\/dkr176","volume":"66","author":"C Grenier","year":"2011","unstructured":"Grenier C, P\u00e9pin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother. 2011;66(7):1617\u201324.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"188_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jinf.2013.03.003","volume":"67","author":"DM Musher","year":"2013","unstructured":"Musher DM, Roig IL, Cazares G, et al. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect. 2013;67(1):11\u20138.","journal-title":"J Infect"},{"issue":"8","key":"188_CR11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/cid\/cis022","volume":"54","author":"GJ Moran","year":"2012","unstructured":"Moran GJ, Krishnadasan A, Gorwitz RJ, et al. EMERGEncy ID NET study Group. Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis. 2012;54(8):1126\u201333.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"188_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/cid\/ciw300","volume":"63","author":"WH Self","year":"2016","unstructured":"Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus Community-acquired pneumonia: Prevalence, clinical Characteristics, and outcomes. Clin Infect Dis. 2016;63(3):300\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"188_CR13","first-page":"29","volume":"115","author":"E Munson","year":"2016","unstructured":"Munson E, Block T, Bowles E, et al. Surveillance of Wisconsin antibacterial susceptibility patterns. WMJ. 2016;115(1):29\u201336.","journal-title":"WMJ"},{"key":"188_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med. 2015;373:415\u201327.","journal-title":"N Engl J Med"},{"key":"188_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cid\/cit734","volume":"58","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Rother C, Salih W, et al. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014;58:330\u20139.","journal-title":"Clin Infect Dis"},{"key":"188_CR16","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1128\/AAC.02582-14","volume":"58","author":"AE Gross","year":"2014","unstructured":"Gross AE, Van Schooneveld TC, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014;58:5262\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"188_CR17","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","volume":"128","author":"MH Kollef","year":"2005","unstructured":"Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854\u201362.","journal-title":"Chest"},{"key":"188_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2014.10.017","volume":"109","author":"BJ Webb","year":"2015","unstructured":"Webb BJ, Dascomb K, Stenehjem E, Dean N. Predicting risk of drugresistant organisms in pneumonia: moving beyond the HCAP model. Respir Med. 2015;109:1\u201310.","journal-title":"Respir Med"},{"key":"188_CR19","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","volume":"16","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Reyes LF, Faverio P, et al. GLIMP Investigators. Global initiative for methicillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016;16:1364\u201376.","journal-title":"Lancet Infect Dis"},{"key":"188_CR20","doi-asserted-by":"publisher","first-page":"1701190","DOI":"10.1183\/13993003.01190-2017","volume":"52","author":"MI Restrepo","year":"2018","unstructured":"Restrepo MI, Babu BL, Reyes LF, et al. GLIMP. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018;52:1701190.","journal-title":"Eur Respir J"},{"issue":"9","key":"188_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/cid\/civ629","volume":"61","author":"BE Jones","year":"2015","unstructured":"Jones BE, Jones MM, Huttner B, et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006\u20132010. Clin Infect Dis. 2015;61(9):1403\u201310.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"188_CR22","doi-asserted-by":"publisher","first-page":"ofx088","DOI":"10.1093\/ofid\/ofx088","volume":"4","author":"S Tomczyk","year":"2017","unstructured":"Tomczyk S, Jain S, Bramley AM, et al. Antibiotic prescribing for adults hospitalized in the etiology of pneumonia in the community study. Open Forum Infect Dis. 2017;4(2):ofx088.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"188_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1017\/S0950268807008564","volume":"136","author":"SA Skull","year":"2008","unstructured":"Skull SA, Andrews RM, Byrnes GB, et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged\u2009>\u2009or =\u200965 years. Epidemiol Infect. 2008;136(2):232\u201340.","journal-title":"Epidemiol Infect"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00188-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-025-00188-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00188-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:02:52Z","timestamp":1766620972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41479-025-00188-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1186\/s41479-025-00188-6","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript was reviewed and determined exempt by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}